165 related articles for article (PubMed ID: 19370966)
1. [Alterations of c-Myc and c-erbB-2 genes in ovarian tumours].
Pastor T; Popović B; Gvozdenović A; Boro A; Petrović B; Novaković I; Puzović D; Luković L; Milasin J
Srp Arh Celok Lek; 2009; 137(1-2):47-51. PubMed ID: 19370966
[TBL] [Abstract][Full Text] [Related]
2. Concurrent abnormal expression of erbB-2, myc and ras genes is associated with poor outcome of ovarian cancer patients.
Katsaros D; Theillet C; Zola P; Louason G; Sanfilippo B; Isaia E; Arisio R; Giardina G; Sismondi P
Anticancer Res; 1995; 15(4):1501-10. PubMed ID: 7654038
[TBL] [Abstract][Full Text] [Related]
3. DNA ploidy and MYC DNA amplification in ovarian carcinomas. Correlation with p53 and bcl-2 expression, proliferative activity and prognosis.
Diebold J; Suchy B; Baretton GB; Blasenbreu S; Meier W; Schmidt M; Rabes H; Löhrs U
Virchows Arch; 1996 Nov; 429(4-5):221-7. PubMed ID: 8972757
[TBL] [Abstract][Full Text] [Related]
4. Oncogene patterns in breast and ovarian carcinomas.
Csókay B; Papp J; Besznyák I; Bösze P; Sárosi Z; Tóth J; Zalay Z; Oláh E
Eur J Surg Oncol; 1993 Dec; 19(6):593-9. PubMed ID: 7903645
[TBL] [Abstract][Full Text] [Related]
5. Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review).
Aunoble B; Sanches R; Didier E; Bignon YJ
Int J Oncol; 2000 Mar; 16(3):567-76. PubMed ID: 10675491
[TBL] [Abstract][Full Text] [Related]
6. Amplifications of proto-oncogenes in ovarian carcinoma.
Bian M; Fan Q; Huang S; Ma J; Lang J
Chin Med J (Engl); 1995 Nov; 108(11):844-8. PubMed ID: 8585978
[TBL] [Abstract][Full Text] [Related]
7. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
[TBL] [Abstract][Full Text] [Related]
8. Amplification and overexpression of the L-MYC proto-oncogene in ovarian carcinomas.
Wu R; Lin L; Beer DG; Ellenson LH; Lamb BJ; Rouillard JM; Kuick R; Hanash S; Schwartz DR; Fearon ER; Cho KR
Am J Pathol; 2003 May; 162(5):1603-10. PubMed ID: 12707044
[TBL] [Abstract][Full Text] [Related]
9. [Genetic alterations in the genesis and development of ovarian cancer].
Okamoto A; Yokoyama S; Terashima Y
Gan To Kagaku Ryoho; 1992 Oct; 19(12):1971-6. PubMed ID: 1358031
[TBL] [Abstract][Full Text] [Related]
10. c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma.
Tavassoli M; Quirke P; Farzaneh F; Lock NJ; Mayne LV; Kirkham N
Br J Cancer; 1989 Oct; 60(4):505-10. PubMed ID: 2572268
[TBL] [Abstract][Full Text] [Related]
11. Expression and amplification of the HER-2/neu (c-erbB-2) protooncogene in epithelial ovarian tumors and cell lines.
Tyson FL; Boyer CM; Kaufman R; O'Briant K; Cram G; Crews JR; Soper JT; Daly L; Fowler WC; Haskill JS
Am J Obstet Gynecol; 1991 Sep; 165(3):640-6. PubMed ID: 1679963
[TBL] [Abstract][Full Text] [Related]
12. c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH.
Wang ZR; Liu W; Smith ST; Parrish RS; Young SR
Exp Mol Pathol; 1999 Jun; 66(2):140-8. PubMed ID: 10409442
[TBL] [Abstract][Full Text] [Related]
13. [Amplification of proto-oncogenes C-myc, C-N-ras, C-Ki-ras, C-erbB2 in ovarian carcinoma].
Bian M; Fan Q; Huang S
Zhonghua Fu Chan Ke Za Zhi; 1995 Jul; 30(7):406-9. PubMed ID: 7587576
[TBL] [Abstract][Full Text] [Related]
14. Expression of c-erbB-2, c-myc, and c-ras oncoproteins, insulin-like growth factor receptor I, and epidermal growth factor receptor in ovarian carcinoma.
van Dam PA; Vergote IB; Lowe DG; Watson JV; van Damme P; van der Auwera JC; Shepherd JH
J Clin Pathol; 1994 Oct; 47(10):914-9. PubMed ID: 7962604
[TBL] [Abstract][Full Text] [Related]
15. Protooncogene amplification and tumor ploidy in human ovarian neoplasms.
Sasano H; Garrett CT; Wilkinson DS; Silverberg S; Comerford J; Hyde J
Hum Pathol; 1990 Apr; 21(4):382-91. PubMed ID: 1969381
[TBL] [Abstract][Full Text] [Related]
16. Amplification of protooncogenes in surgical specimens of human lung carcinomas.
Shiraishi M; Noguchi M; Shimosato Y; Sekiya T
Cancer Res; 1989 Dec; 49(23):6474-9. PubMed ID: 2573414
[TBL] [Abstract][Full Text] [Related]
17. Amplification of the C-erbB-2(HER-2/neu) proto-oncogene in ovarian carcinomas.
Fan QB; Bian ML; Huang SZ; Lang JH; Ma J; Liu WS; Xu XY
Chin Med J (Engl); 1994 Aug; 107(8):589-93. PubMed ID: 7805442
[TBL] [Abstract][Full Text] [Related]
18. DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours.
Courjal F; Cuny M; Rodriguez C; Louason G; Speiser P; Katsaros D; Tanner MM; Zeillinger R; Theillet C
Br J Cancer; 1996 Dec; 74(12):1984-9. PubMed ID: 8980401
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathology of ovarian carcinomas.
Matias-Guiu X; Prat J
Virchows Arch; 1998 Aug; 433(2):103-11. PubMed ID: 9737787
[TBL] [Abstract][Full Text] [Related]
20. Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancer.
Berns EM; Klijn JG; Henzen-Logmans SC; Rodenburg CJ; van der Burg ME; Foekens JA
Int J Cancer; 1992 Sep; 52(2):218-24. PubMed ID: 1325950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
